131 related articles for article (PubMed ID: 23958879)
1. NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload.
Zong J; Salim M; Zhou H; Bian ZY; Dai J; Yuan Y; Deng W; Zhang JY; Zhang R; Wu QQ; Tang QZ
Lab Invest; 2013 Oct; 93(10):1128-36. PubMed ID: 23958879
[TBL] [Abstract][Full Text] [Related]
2. RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice.
Zhao CH; Ma X; Guo HY; Li P; Liu HY
Biochem Biophys Res Commun; 2017 Nov; 493(2):1151-1158. PubMed ID: 28698147
[TBL] [Abstract][Full Text] [Related]
3. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
[TBL] [Abstract][Full Text] [Related]
5. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
[TBL] [Abstract][Full Text] [Related]
6. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
8. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
9. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1.
Zhang X; Zhang MC; Wang CT
Biochem Biophys Res Commun; 2018 Nov; 506(1):137-144. PubMed ID: 30340835
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-κB signaling.
Li Q; Wei G; Tao T
Biochem Biophys Res Commun; 2019 Jan; 509(1):16-23. PubMed ID: 30581005
[TBL] [Abstract][Full Text] [Related]
11. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
[TBL] [Abstract][Full Text] [Related]
12. IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.
Dai J; Shen DF; Bian ZY; Zhou H; Gan HW; Zong J; Deng W; Yuan Y; Li F; Wu QQ; Gao L; Zhang R; Ma ZG; Li HL; Tang QZ
PLoS One; 2013; 8(1):e53412. PubMed ID: 23349709
[TBL] [Abstract][Full Text] [Related]
13. Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.
Xiao J; Jiang H; Zhang R; Fan G; Zhang Y; Jiang D; Li H
PLoS One; 2012; 7(5):e35779. PubMed ID: 22606234
[TBL] [Abstract][Full Text] [Related]
14. Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1.
Wang Q; Ma S; Li D; Zhang Y; Tang B; Qiu C; Yang Y; Yang D
Am J Hypertens; 2014 Dec; 27(12):1521-9. PubMed ID: 24858305
[TBL] [Abstract][Full Text] [Related]
15. NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice.
Li X; Li F; Chu Y; Wang X; Zhang H; Hu Y; Zhang Y; Wang Z; Wei X; Jian W; Zhang X; Yi F
Cell Physiol Biochem; 2013; 32(6):1857-66. PubMed ID: 24356239
[TBL] [Abstract][Full Text] [Related]
16. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.
Bansal T; Chatterjee E; Singh J; Ray A; Kundu B; Thankamani V; Sengupta S; Sarkar S
J Biol Chem; 2017 Oct; 292(40):16440-16462. PubMed ID: 28821620
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium.
Richardson WM; Sodhi CP; Russo A; Siggers RH; Afrazi A; Gribar SC; Neal MD; Dai S; Prindle T; Branca M; Ma C; Ozolek J; Hackam DJ
Gastroenterology; 2010 Sep; 139(3):904-17, 917.e1-6. PubMed ID: 20580721
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro.
Ren J; Zhang N; Liao H; Chen S; Xu L; Li J; Yang Z; Deng W; Tang Q
Life Sci; 2017 Jul; 181():53-61. PubMed ID: 28449869
[TBL] [Abstract][Full Text] [Related]
19. Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling.
Jiang DS; Zhang XF; Gao L; Zong J; Zhou H; Liu Y; Zhang Y; Bian ZY; Zhu LH; Fan GC; Zhang XD; Li H
Hypertension; 2014 Jan; 63(1):96-104. PubMed ID: 24101669
[TBL] [Abstract][Full Text] [Related]
20. Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.
Deng KQ; Zhao GN; Wang Z; Fang J; Jiang Z; Gong J; Yan FJ; Zhu XY; Zhang P; She ZG; Li H
Circulation; 2018 Apr; 137(14):1486-1504. PubMed ID: 29229612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
